83 FR 23584 - Medicare Program; CY 2018 Updates to the Quality Payment Program; and Quality Payment Program: Extreme and Uncontrollable Circumstance Policy for the Transition Year; Corrections

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services

Federal Register Volume 83, Issue 99 (May 22, 2018)

This document corrects technical errors that appeared in the final rule with comment period and interim final rule with comment period published in the Federal Register on November 16, 2017 entitled ``Medicare Program; CY 2018 Updates to the Quality Payment Program; and Quality Payment Program: Extreme and Uncontrollable Circumstance Policy for the Transition Year'' (hereinafter referred to as the ``CY 2018 Quality Payment Program final rule'').

[Federal Register Volume 83, Number 99 (Tuesday, May 22, 2018)]
[Rules and Regulations]
[Pages 23584-23610]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-10923]



[[Page 23584]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

42 CFR Part 414

[CMS-5522-F2]
RIN 0938-AT13


Medicare Program; CY 2018 Updates to the Quality Payment Program; 
and Quality Payment Program: Extreme and Uncontrollable Circumstance 
Policy for the Transition Year; Corrections

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Final rule with comment period and interim final rule with 
comment period; correction and correcting amendment.

-----------------------------------------------------------------------

SUMMARY: This document corrects technical errors that appeared in the 
final rule with comment period and interim final rule with comment 
period published in the Federal Register on November 16, 2017 entitled 
``Medicare Program; CY 2018 Updates to the Quality Payment Program; and 
Quality Payment Program: Extreme and Uncontrollable Circumstance Policy 
for the Transition Year'' (hereinafter referred to as the ``CY 2018 
Quality Payment Program final rule'').

DATES: This correction is effective May 22, 2018.

FOR FURTHER INFORMATION CONTACT: 
    Molly MacHarris, (410) 786-4461, for inquiries related to MIPS.
    Benjamin Chin, (410) 786-0679, for inquiries related to APMs.

SUPPLEMENTARY INFORMATION:

I. Background

    In FR Doc. 2017-24067 (82 FR 53568), the final rule with comment 
period and interim final rule with comment period there were a number 
of technical errors that are identified and corrected in the Correction 
of Errors section of this correcting document. The provisions in this 
correction document are effective as if they had been included in the 
document published in the Federal Register on November 16, 2017. 
Accordingly, the corrections are applicable for program years beginning 
January 1, 2018.

II. Summary of Errors

A. Summary of Errors in Preamble

    On page 53577, we inadvertently made an error in citing the 
incremental collection of information-related burden.
    On page 53743, we inadvertently made an error in identifying the 
regulation text citation.
    On page 53744, we inadvertently made an error in identifying the 
regulation text citation.
    On page 53900, we inadvertently made an error in citing the 
reduction in burden cost relative to a baseline of continuing the 
policies in the CY 2017 Quality Payment Program final rule.
    On page 53911, we inadvertently made an error in citing the 
estimated data submission burden for the Quality Payment Program.
    On page 53925, we inadvertently made an error in citing the total 
estimated labor cost for annual recordkeeping and data submission.
    On page 53925, we inadvertently made an error in citing the 
decrease in labor cost burden relative to the estimated baseline of 
continued transition year policies.
    On page 53925, Table 74--Annual Recordkeeping And Submission 
Requirements
    a. Sixth column titled ``Total annual burden cost'', second row, we 
inadvertently made an error in citing the total annual burden cost for 
QCDR and Registries self-nomination.
    b. Sixth column titled ``Total annual burden cost'', nineteenth 
row, we inadvertently made an error in citing the total annual burden 
cost.
    On page 53927, we inadvertently made an error in citing the 
reduction in burden costs in the Quality Payment Program Year 2 
relative to Quality Payment Program Year 1.
    On page 53950, we inadvertently made an error in citing the 
collection of information-related burden associated with the CY 2018 
Quality Payment Program final rule with comment period.
    On page 53950, we inadvertently made an error in citing the 
reduction in incremental collection of information-related burden 
associated with the CY 2018 Quality Payment Program final rule with 
comment period relative to the baseline burden of continuing the 
policies and information collections set forth in the CY 2017 Quality 
Program final rule.
    On page 53950, Table 81--Additional Costs And Benefits, in the 
second column titled ``Costs/benefits'', second row, we inadvertently 
made an error in citing the incremental collection of information/
Paperwork Reduction Act burden estimates.

B. Summary of Errors in Regulation Text

    On page 53954, in the regulation text at Sec.  
414.1370(g)(1)(ii)(B), we inadvertently made errors in identifying the 
beginning CY performance period for which CMS calculates a quality 
improvement score for an APM Entity.
    On page 53954, at 414.1370(h)(5)(i)(B), due to typographical 
errors, the percent values for the advancing care information 
performance category and the improvement activities performance 
category are incorrect.
    On page 53957, we inadvertently made an error in identifying the 
regulation text citation.
    On page 53961, at Sec.  414.1420(d)(3)(i), we inadvertently deleted 
the existing regulation text regarding the expected expenditures 
standard.

C. Summary of Errors in Appendix

    On page 53969, Table A.3. Average Change in Leg Pain following 
Lumbar Discectomy/Laminotomy, Quality #461, we inadvertently omitted 
the MAP recommendation description in the ``Rationale''.
    On page 53970, Table A.4. Bone Density Evaluation for Patients with 
Prostate Cancer and Receiving Androgen Deprivation Therapy, Quality 
#462, we incorrectly identified the MAP recommendation description in 
the ``Rationale''.
    On page 53971, Table A.5. Prevention of Post-Operative Vomiting 
(POV)--Combination Therapy (Pediatrics), Quality #463 we inadvertently 
omitted the MAP recommendation description in the ``Rationale''.
    On page 53973, Table A.7. Uterine Artery Embolization Technique: 
Documentation of Angiographic Endpoints and Interrogation of Ovarian 
Arteries, Quality #465, we inadvertently omitted the MAP recommendation 
description in the ``Rationale''.
    On page 53976, Table B.1. Allergy/Immunology in the first column 
titled ``Indicator'', third row, we inadvertently omitted the high 
priority symbol.
    On page 53977, Table B.1. Allergy/Immunology (continued) in the 
first column titled ``Indicator'', second row, we inadvertently omitted 
the high priority symbol.
    On page 53978, Table B.1. Allergy/Immunology (continued) in the 
first column titled ``Indicator'', third row, we inadvertently omitted 
the CORE measure and the high priority symbols.
    On page 53985, Table B.3. Cardiology (continued) in the first 
column titled ``Indicator'',
    a. Third row, we inadvertently omitted the CORE measure and the 
high priority symbols.
    b. Fourth row, we inadvertently omitted the high priority symbol.
    On page 53986, Table B.3. Cardiology (continued) in the first 
column titled

[[Page 23585]]

``Indicator'', first row, we inadvertently omitted the high priority 
symbol.
    On page 53987, Table B.3. Cardiology (continued) in the first 
column titled ``Indicator'', fifth row, we inadvertently omitted the 
high priority symbol.
    On page 53992, Table B.4. Gastroenterology (continued) in the first 
column titled ``Indicator'', third row, we inadvertently omitted the 
CORE measure symbol.
    On page 53997, Table B.5. Dermatology (continued),
    a. First column titled ``Indicator'', third row, we inadvertently 
omitted the high priority symbol.
    b. Fifth column titled ``Data Submission Method'', second row, we 
inadvertently listed an incorrect claims submission method.
    On page 54006, Table B.7. Family Medicine (continued) in the fourth 
column titled ``CMS E-measure ID'', fifth row, we inadvertently listed 
an incorrect E-measure ID.
    On page 54007, Table B.7. Family Medicine (continued) in the first 
column titled ``Indicator'', second row, we inadvertently omitted the 
high priority symbol.
    On page 54009, Table B.7. Family Medicine (continued) in the first 
column titled ``Indicator'', first and second rows, we inadvertently 
omitted the high priority symbol.
    On page 54010, Table B.7. Family Medicine (continued),
    a. Second column titled ``NQF#'', third row, due to a typographical 
error, we included an incorrect NQF#.
    b. Ninth column titled ``Measure Steward'', third row, we 
inadvertently omitted the Centers for Medicare & Medicaid Services 
(CMS) as a co-steward.
    On page 54012, Table B.7. Family Medicine (continued) in the first 
column titled ``Indicator'', fifth row, we inadvertently omitted the 
high priority symbol.
    On page 54013, Table B.7. Family Medicine (continued) in the first 
column titled ``Indicator'', first row, we inadvertently omitted the 
high priority symbol.
    On page 54023, Table B.8. Internal Medicine (continued), in the 
first column titled ``Indicator'', First and second rows, we 
inadvertently omitted the high priority symbol.
    On pages 54024, Table B.8. Internal Medicine (continued),
    a. Second column titled ``NQF#'', third row, due to a typographical 
error, we included an incorrect NQF#.
    b. Ninth column titled ``Measure Steward'', third row, we 
inadvertently omitted the Centers for Medicare & Medicaid Services 
(CMS) as a co-steward.
    On page 54027, Table B.8. Internal Medicine (continued), in the 
first column titled ``Indicator'', third and fifth rows, we 
inadvertently omitted the high priority symbol.
    On page 54036, Table B.9. Obstetrics/Gynecology (continued), in the 
first column titled ``Indicator'', sixth row, we inadvertently omitted 
the high priority symbol.
    On page 54037, Table B.9. Obstetrics/Gynecology (continued), in the 
first column titled ``Indicator'', second and fourth rows, we 
inadvertently omitted the high priority symbol.
    On page 54038, Table B.9. Obstetrics/Gynecology (continued), ninth 
column, fourth row, we inadvertently listed an incorrect measure 
steward.
    On page 54047, Table B.11. Orthopedic Surgery (continued) in the 
first column titled ``Indicator'', fifth row, we inadvertently omitted 
the high priority symbol.
    On page 54049, Table B.11. Orthopedic Surgery (continued) in the 
first column titled ``Indicator'', third row, we inadvertently omitted 
the substantive change symbol.
    On page 54079, Table B.18. Neurology (continued) in the first 
column titled ``Indicator'',
    a. Third and fourth rows, we inadvertently omitted the substantive 
change symbol.
    b. Third row, the measure title and description are inconsistent 
with the finalized substantive change, which is described in Table 
E.12.
    On page 54082, for Table B.18. Neurology (continued), we 
inadvertently included duplicate entries for Quality #286.
    On page 54086, Table B.19. Mental/Behavioral Health (continued) in 
the first column titled ``Indicator'',
    a. Third row, we inadvertently omitted the substantive change 
symbol.
    b. Third row, the measure title and description are inconsistent 
with the finalized substantive change, which is described in Table 
E.12.
    On page 54089, Table B.19. Mental/Behavioral Health (continued) in 
the fourth column titled ``CMS E-Measure ID'', fourth row, we 
inadvertently listed an incorrect E-measure ID.
    On page 54091, Table B.19. Mental/Behavioral Health (continued), we 
inadvertently included duplicate entries for Quality #286.
    On page 54094, Table B.20a. Diagnostic Radiology (continued) in the 
first column titled ``Indicator'', first row, we inadvertently omitted 
the high priority symbol.
    On page 54098, Table B.20b. Interventional Radiology (continued) in 
the first column titled ``Indicator'', fifth row, we inadvertently 
omitted the high priority symbol.
    On page 54099, Table B.20b. Interventional Radiology (continued) in 
the first column titled ``Indicator'', second row, we inadvertently 
omitted the high priority symbol.
    On page 54102, Table B.21. Nephrology (continued) in the first 
column titled ``Indicator'', second row, we inadvertently omitted the 
high priority symbol.
    On page 54103, Table B.21. Nephrology (continued) in the first 
column titled ``Indicator'',
    a. First and third rows, we inadvertently omitted the high priority 
symbol.
    b. Second row, we inadvertently omitted the CORE measure symbol.
    On page 54109, Table B.23. Vascular Surgery (continued) in the 
first column titled ``Indicator'', third row, we inadvertently omitted 
the high priority and CORE measure symbols.
    On page 54112, Table B.23. Vascular Surgery (continued) in the 
first column titled ``Indicator'', third row, we inadvertently omitted 
the high priority symbol.
    On page 54113, Table B.23. Vascular Surgery (continued) in the 
third column titled ``Quality#'', first row, due to a typographical 
error, the Quality# for the measure title and description was 
incorrect.
    On page 54116, Table B.24. Thoracic Surgery (continued) in the 
first column titled ``Indicator'', fourth row, we inadvertently omitted 
the high priority and CORE measure symbols.
    On page 54118, Table B.24. Thoracic Surgery (continued) in the 
first column titled ``Indicator'', first row, we inadvertently omitted 
the high priority and CORE measure symbols.
    On page 54121, Table B.25. Urology (continued) in the first column 
titled ``Indicator'', first row, we inadvertently omitted the high 
priority symbol.
    On page 54122, Table B.25. Urology (continued) in the first column 
titled ``Indicator'', fifth row, we inadvertently omitted the high 
priority symbol.
    On page 54123, Table B.25. Urology (continued) in the first column 
titled ``Indicator'',
    a. First, second, and third rows, we inadvertently omitted the high 
priority symbol.
    On page 54124, Table B.26. Oncology in the first column titled 
``Indicator'', third row, we inadvertently omitted the high priority 
symbol.
    On page 54130, Table B.27. Hospitalists (continued) in the first 
column titled ``Indicator'', first row, we inadvertently omitted the 
high priority symbol.

[[Page 23586]]

    On page 54134, Table B.28. Rheumatology (continued) in the first 
column titled ``Indicator'', second row, we inadvertently omitted the 
high priority symbol.
    On page 54136, Table B.29. Infectious Disease (continued) in the 
first column titled ``Indicator'', second row, we inadvertently omitted 
the high priority symbol.
    On page 54137, Table B.29. Infectious Disease (continued) in the 
first column titled ``Indicator'', second row, we inadvertently omitted 
the CORE measure symbol.
    On page 54138, Table B.29. Infectious Disease (continued) in the 
first column titled ``Indicator'', fifth row, we inadvertently omitted 
the high priority and CORE measure symbols.
    On page 54139, Table B.29. Infectious Disease (continued) in the 
first column titled ``Indicator'', first row, we inadvertently omitted 
the high priority symbol.
    On page 54141, Table B.30. Neurosurgical (continued) in the first 
column titled ``Indicator'', third row, we inadvertently omitted the 
high priority symbol.
    On page 54142, Table B.30. Neurosurgical (continued) in the first 
column titled ``Indicator'',
    a. Fourth and fifth rows, we inadvertently omitted the high 
priority symbol.
    On page 54145, Table B.31. Podiatry (continued) in the first column 
titled ``Indicator'', first row, we inadvertently omitted the CORE 
measure symbol.
    On page 54146, Table B.32. Dentistry (continued) in the first 
column titled ``Indicator'', first row, we inadvertently omitted the 
high priority symbol.
    On page 54163, Table E.1. CAHPS for MIPS Clinician/Group Survey
    a. First row titled ``NQF#'', due to a typographical error, we 
included an incorrect NQF#.
    b. Seventh row titled ``Substantive Change'', we inadvertently 
omitted the SSMs that remain for the measure.
    c. Eighth row titled ``Steward'', we inadvertently omitted the 
Centers for Medicare & Medicaid Services (CMS) as a co-steward.
    On page 54204, in Table G: Improvement Activities with Changes for 
the Quality Payment Program Year 2 and Future Years,
    a. Eighteenth row, titled ``Response'', we inadvertently added 
qualifier language that was incorrect.
    b. Nineteenth row, titled ``Rationale'' we inadvertently added 
qualifier language that was incorrect.
    On page 54216, in Table G: Improvement Activities with Changes for 
the Quality Payment Program Year 2 and Future Years, thirty-ninth row, 
titled ``Currently Eligible for Advancing Care Information Bonus'', we 
incorrectly stated that this activity was not eligible for the 
Advancing Care Information Bonus. IA_PM_13 is eligible for the 
Advancing Care Information Bonus.

III. Waiver of Proposed Rulemaking, 60-Day Comment Period, and Delay in 
Effective Date

    Under 5 U.S.C. 553(b) of the Administrative Procedure Act (APA), 
the agency is required to publish a notice of the proposed rule in the 
Federal Register before the provisions of a rule take effect. 
Similarly, section 1871(b)(1) of the Act requires the Secretary to 
provide for notice of the proposed rule in the Federal Register and 
provide a period of not less than 60 days for public comment. In 
addition, section 553(d) of the APA, and section 1871(e)(1)(B)(i) of 
the Act mandate a 30-day delay in effective date after issuance or 
publication of a rule. Sections 553(b)(B) and 553(d)(3) of the APA 
provide for exceptions from the notice and comment and delay in 
effective date APA requirements; in cases in which these exceptions 
apply, sections 1871(b)(2)(C) and 1871(e)(1)(B)(ii) of the Act provide 
exceptions from the notice and 60-day comment period and delay in 
effective date requirements of the Act as well. Section 553(b)(B) of 
the APA and section 1871(b)(2)(C) of the Act authorize an agency to 
dispense with normal rulemaking requirements for good cause if the 
agency makes a finding that the notice and comment process are 
impracticable, unnecessary, or contrary to the public interest. In 
addition, both section 553(d)(3) of the APA and section 
1871(e)(1)(B)(ii) of the Act allow the agency to avoid the 30-day delay 
in effective date where such delay is contrary to the public interest 
and an agency includes a statement of support.
    We believe that this correcting document does not constitute a rule 
that would be subject to the notice and comment or delayed effective 
date requirements. The document corrects technical errors in the CY 
2018 Quality Payment Program final rule, but does not make substantive 
changes to the policies or payment methodologies that were adopted in 
the final rule. As a result, this correcting document is intended to 
ensure that the information in the CY 2018 Quality Payment Program 
final rule accurately reflects the policies adopted in that document.
    In addition, even if this were a rule to which the notice and 
comment procedures and delayed effective date requirements applied, we 
find that there is good cause to waive such requirements. Undertaking 
further notice and comment procedures to incorporate the corrections in 
this document into the final rule or delaying the effective date would 
be contrary to the public interest because it is in the public's 
interest for providers to receive appropriate payments in as timely a 
manner as possible, and to ensure that the CY 2018 Quality Payment 
Program final rule accurately reflects our methodologies and policies. 
Furthermore, such procedures would be unnecessary, as we are not making 
substantive changes to our methodologies or policies, but rather, we 
are simply implementing correctly the methodologies and policies that 
we previously proposed, requested comment on, and subsequently 
finalized. This correcting document is intended solely to ensure that 
the CY 2018 Quality Payment Program final rule accurately reflects 
these methodologies and policies. Therefore, we believe we have good 
cause to waive the notice and comment and effective date requirements.

IV. Correction of Errors

    In FR Doc. 2017-24067 (82 FR 53568), make the following 
corrections:

A. Correction of Errors in Preamble

    1. On page 53577, second column, second full paragraph, line 10, 
the phrase ``of approximately $13.9 million relative'' is corrected to 
read ``of approximately $14.2 million relative''.
    2. On page 53743, second column, first full paragraph, under the 
heading ``(iii) Additional Requirement for Full Participation To 
Measure Improvement for Quality Performance Category'', line 7, the 
reference ``Sec.  414.1330'' is corrected to read ``Sec.  414.1335''.
    3. On page 53744, third column, third full paragraph, line 6, the 
reference ``Sec.  414.1330'' is corrected to read ``Sec.  414.1335''.
    4. On page 53900, second column, first partial paragraph, line 7, 
the phrase ``burden cost of approximately $13.9'' is corrected to read 
``burden cost of approximately $14.2''.
    5. On page 53911, third column, second full paragraph, line 3, the 
phrase ``approximately $695 million'' is corrected to read 
``approximately $694 million''.
    6. On page 53925, first column, second full paragraph, line 6, the 
phrase ``total labor cost of $694,183,802'' is corrected to read 
``total labor cost of ``$693,949,289''.
    7. On page 53925, third column, first full paragraph, line 3, the 
phrase ``by 171,264 hours and $13.9 million in'' is

[[Page 23587]]

corrected to read ``by 171,264 hours and $14.2 million in''.
    8. On page 53925, in Table 74--Annual Recordkeeping And Submission 
Requirements, sixth column, row 2, the total annual burden cost for 
QCDR and Registries self-nomination ``439,786'' is corrected to read 
``205,273''.
    9. On page 53925, in Table 74--Annual Recordkeeping And Submission 
Requirements, sixth column, row 19, the total annual burden cost 
``694,183,802'' is corrected to read ``693,949,289''.
    10. On page 53927, first column, first partial paragraph, line 4, 
the phrase ``costs of $13.9 million in the Quality'' is corrected to 
read ``costs of $14.2 million in the Quality''.
    11. On page 53950, first column, first full paragraph, line 4, the 
phrase ``will result in approximately $695'' is corrected to read 
``will result in approximately $694''.
    12. On page 53950, second column, first partial paragraph, line 2, 
the phrase ``period is and approximately $13.9'' is corrected to read 
``period is and approximately $14.2''.
    13. On page 53950, Table 81, Additional Costs And Benefits second 
column, Costs/benefits second row, the dollar value ``$13.9 million'' 
is corrected to read ``$14.2 million''.

B. Correction of Errors in Appendix

    1. On page 53969, in Table A.3. Average Change in Leg Pain 
following Lumbar Discectomy/Laminotomy, the listed entry is corrected 
to read as follows:
BILLING CODE 4120-01-P
[GRAPHIC] [TIFF OMITTED] TR22MY18.000

    2. On page 53970, in Table A.4. Bone Density Evaluation for 
Patients with Prostate Cancer and Receiving Androgen Deprivation 
Therapy, the listed entry is corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.001

    3. On page 53971, in Table A.5, Prevention of Post-Operative 
Vomiting (POV)--Combination Therapy (Pediatrics) the listed entry is 
corrected to read as follows:

[[Page 23588]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.002

    4. On page 53973, in Table A.7, Uterine Artery Embolization 
Technique: Documentation of Angiographic Endpoints and Interrogation of 
Ovarian Arteries, the listed entry is corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.003

    5. On pages 53976, 53977 and 53978, in Table B.1 Allergy/
Immunology, the listed entries are corrected to read as follows:

[[Page 23589]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.004

    6. On pages 53985, 53986, and 53987, in Table B.3 Cardiology 
(continued), the listed entries are corrected to read as follows:

[[Page 23590]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.005

    7. On page 53992, in Table B.4 Gastroenterology (continued), the 
listed entry is corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.006

    8. On page 53997, in Table B.5 Dermatology (continued), the listed 
entries are corrected to read as follows:

[[Page 23591]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.007

    9. On page 54006, 54007, 54009, 54010, 54012, and 54013, in Table 
B.7 Family Medicine (continued) the listed entries are corrected to 
read as follows:

[[Page 23592]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.008


[[Page 23593]]


[GRAPHIC] [TIFF OMITTED] TR22MY18.009

    10. On pages 54023, 54024, and 54027, in Table B.8 Internal 
Medicine (continued), the listed entries are corrected to read as 
follows:

[[Page 23594]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.010


[[Page 23595]]


[GRAPHIC] [TIFF OMITTED] TR22MY18.011

    11. On pages 54036, 54037, and 54038, in Table B.9 Obstetrics/
Gynecology (continued), the listed entries are corrected to read as 
follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.012

    12. On pages 54047 and 54049, in Table B.11 Orthopedic Surgery 
(continued), the listed entries are corrected to read as follows:

[[Page 23596]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.013

    13. On page 54079, in Table B.18 Neurology (continued), the listed 
entries are corrected to read as follows:

[[Page 23597]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.014

    14. On page 54082, in Table B.18 Neurology (continued), the third 
row (including the Quality #286) is removed.
    15. On page 54086, 54089, and 54091, in Table B.19 Mental/
Behavioral Health (continued), the listed entries are corrected to read 
as follows:

[[Page 23598]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.015

    16. On page 54091, in Table B.19 Mental/Behavioral Health 
(continued), the third row (including the Quality #286) is removed.
    17. On page 54094, in Table B.20a Diagnostic Radiology (continued), 
the listed entry is corrected to read as follows:

[[Page 23599]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.016

    18. On page 54098 and 54099, in Table B.20b Interventional 
Radiology, the listed entries are corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.017

    19. On pages 54102 and 54103, in Table B.21 Nephrology (continued), 
the listed entries are corrected to read as follows:

[[Page 23600]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.018

    20. On pages 54109, 54112, and 54113, in Table B.23 Vascular 
Surgery (continued), the listed entries are corrected to read as 
follows:

[[Page 23601]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.019

    21. On pages 54116 and 54118, in Table B.24 Thoracic Surgery 
(continued), the listed entries are corrected to read as follows:

[[Page 23602]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.020

    22. On page 54121, 54122, and 54123, in Table B.25 Urology 
(continued), the listed entries are corrected to read as follows:

[[Page 23603]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.021

    23. On page 54124, in Table B.26 Oncology, the listed entry is 
corrected to read as follows:

[[Page 23604]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.022

    24. On page 54130, in Table B.27 Hospitalists (continued), the 
listed entry is corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.023

    25. On page 54134, Table B.28 Rheumatology (continued), the listed 
entry is corrected to read as follows:

[[Page 23605]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.024

    26. On pages 54136, 54137, 54138, and 54139, in Table B.29. 
Infectious Disease (continued), the listed entries are corrected to 
read as follows:

[[Page 23606]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.025

    27. On pages 54141 and 54142, in Table B.30 Neurosurgical, the 
listed entries are corrected to read as follows:

[[Page 23607]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.026

    28. On page 54145, in Table B.31 Podiatry (continued), the listed 
entry is corrected to read as follows:

[[Page 23608]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.027

    29. On page 54146, in Table B.32 Dentistry, the listed entry is 
corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.028

    30. On page 54163, in Table E.1, CAHPS for MIPS Clinician/Group 
Survey, the listed entries are corrected to read as follows:

[[Page 23609]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.029

    31. On page 54204, in Table G Improvement Activities with Changes 
for the Quality Payment Program Year 2 and Future Years, the following 
entries are corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.030

    32. On page 54216, in Table G Improvement Activities with Changes 
for the Quality Payment Program Year 2 and Future Years, the following 
entries are corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.031

BILLING CODE 4120-01-C

List of Subjects in 42 CFR Part 414

    Administrative practice and procedure, Biologics, Drugs, Health 
facilities, Health professions, Diseases, Medicare, Reporting and 
recordkeeping requirements.

    Accordingly, 42 CFR chapter IV is corrected by making the following 
correcting amendments:

[[Page 23610]]

PART 414--PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES

0
1. The authority citation for part 414 continues to read as follows:

    Authority: Secs. 1102, 1871, and 1881(b)(l) of the Social 
Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(l)).

0
2. Section 414.1370 is amended by revising paragraphs (g)(1)(ii)(B) and 
(h)(5)(i)(B) to read as follows:


Sec.  414.1370  APM scoring standard under MIPS.

* * * * *
    (g) * * *
    (1) * * *
    (ii) * * *
    (B) Quality Improvement Score. Beginning in 2018, for an APM Entity 
for which CMS calculated a total quality performance category score for 
the previous MIPS performance period, CMS calculates a quality 
improvement score for the APM Entity group, as specified in Sec.  
414.1380(b)(1)(xvi).
* * * * *
    (h) * * *
    (5) * * *
    (i) * * *
    (B) Beginning in 2018, the advancing care information performance 
category is reweighted to 75 percent and the improvement activities 
performance category is reweighted to 25 percent.
* * * * *


Sec.  414.1380  [Amended]

0
3. Section 414.1380 is amended in paragraph (b)(1)(xvi)(F) by removing 
the reference ``Sec. Sec.  414.1330'' and adding in its place the 
reference ``Sec. Sec.  414.1335''.

0
4. Section 414.1420 is amended by revising paragraph (d)(3)(i) to read 
as follows:


Sec.  414.1420  Other payer advanced APM criteria.

* * * * *
    (d) * * *
    (3) * * *
    (i) For the 2019 and 2020 QP Performance Periods, 8 percent of the 
total combined revenues from the payer to providers and other entities 
under the payment arrangement if financial risk is expressly defined in 
terms of revenue; or, 3 percent of the expected expenditures for which 
an APM Entity is responsible under the payment arrangement; or
* * * * *

    Dated: May 16. 2018.
Ann C. Agnew,
Executive Secretary to the Department, Department of Health and Human 
Services.
[FR Doc. 2018-10923 Filed 5-21-18; 8:45 am]
 BILLING CODE 4120-01-P